Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines.
about
ESMO gave me a chance to help make a difference: a personal reflection on the occasion of receiving the 2015 ESMO AwardSymptomatic treatment of dyspnea in advanced cancer patients : A narrative review of the current literature.Reply to the letter to the editor 'How much evidence isn't in evidence-based guidelines?' by Johnson et al.How much evidence isn't in evidence-based guidelines?Best Practices Education, Part II: Evidence for and Against Opioid Therapy
P2860
Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines.
@en
Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines.
@nl
type
label
Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines.
@en
Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines.
@nl
prefLabel
Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines.
@en
Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines.
@nl
P2093
P2860
P356
P1433
P1476
Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines.
@en
P2093
ESMO Guidelines Committee
P2860
P304
P356
10.1093/ANNONC/MDV306
P478
26 Suppl 5
P577
2015-09-01T00:00:00Z